#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ductal adenocarcinoma of pancreas Angiosarcoma non-metastatic Synovial sarcoma Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Ovarian cancer stage III Palmoplantar pustulosis Neuropathy peripheral Cystic fibrosis Acute graft versus host disease in liver Eosinophilic oesophagitis Choroid melanoma Nephroblastoma Behcet's syndrome Haemophilia B without inhibitors Amyotrophic lateral sclerosis More trials…

    Learn about Rare Diseases

    Primary mediastinal large B-cell lymphoma – Life with Disease Ewing’s sarcoma metastatic Pleural mesothelioma malignant – Diagnostics Angelman’s syndrome – Basic Information Bronchiolitis obliterans syndrome – Diagnostics Idiopathic inflammatory myopathy – Basic Information Glomerulonephritis rapidly progressive – Treatment Testicular leiomyosarcoma – Basic Information Angiosarcoma – Trials in Disease Loeys-Dietz syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tetracycline Hydrochloride Nesolicaftor Nimodipine Corylus Avellana L. Acenocoumarol Hct116-A Ravulizumab DNL593 Streptococcus Pneumoniae Sodium Nitroprusside Dihydrate Mbs2320 Vgl101 Mecasermin Rinfabate Caraway Oil [18F]Mc225 Valsartan Gentamicin Ganciclovir Sodium Df1001 Abatacept More therapies…

    Learn about Your Condition

    Strongyloidiasis Biliary cancer metastatic Haemoglobinuria Chronic myeloid leukaemia Craniopharyngioma Breast cancer stage II Epithelioid sarcoma Herpes virus infection Thermal burn Cardiac sarcoidosis Encephalitis Japanese B Acute lymphocytic leukaemia Yellow fever Skin candida Substance use disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello…

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello

Via Trabucco 180, Palermo, 90146, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety of Long-Term Use of Deucrictibant for Treating Hereditary Angioedema Attacks in Patients with C1-Inhibitor Deficiency

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    Investigated Drugs:
    • (S)-N-(1-Deutero-1-(3-Chloro-5-Fluoro-2-((2-Methyl-4-(1-Methyl-1H-1,2,4-Triazol-5-Yl)Quinolin-8-Yloxy)Methyl)Phenyl)Ethyl)-2-(Difluoromethoxy)Acetamide
    • Deucrictibant
    • Icatibant
    Austria Bulgaria Czechia France Germany Hungary +8

  • Study on Ibrutinib and Venetoclax for Patients with Untreated Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ibrutinib
    • Venetoclax
    Czechia France Hungary Italy Poland Spain

  • Study on Early Treatment Intensification for Acute Myeloid Leukemia with FLT3 Mutation Using Cytarabine, Midostaurin, and Daunorubicin Hydrochloride for Patients with Low Chemosensitivity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Midostaurin
    • Daunorubicin Hydrochloride
    • Cytarabine
    Italy

  • Study on Tranexamic Acid and Sodium Chloride for Patients with Stroke-Related Brain Bleeding

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cerebrovascular accident
    Investigated Drugs:
    • Tranexamic Acid
    • Sodium Chloride
    Denmark Finland France Ireland Italy Norway +2

  • Long‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)

    Recruiting

    3 1
    Investigated Drugs:
    • ADX-324
    Austria Belgium Bulgaria Croatia Czechia France +5

  • A study of etavopivat to reduce vaso‑occlusive crises in children with sickle cell disease

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Etavopivat
    France Italy The Netherlands Spain

  • Efficacy and Safety of Berotralstat for Preventing Angioedema Attacks in Patients with Acquired Angioedema due to C1 Inhibitor Deficiency

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Berotralstat
    Italy

  • A study to evaluate the effectiveness of MC0518 (mesenchymal stromal cells) in adults with acute graft-versus-host disease that has not responded to steroids and ruxolitinib

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Acute graft versus host disease
    • Graft versus host disease
    Investigated Drugs:
    • Mesenchymal Stromal Cells, Ex Vivo Cultured
    Italy

  • Study of gilteritinib with fludarabine, cytarabine and idarubicin combination therapy in newly diagnosed FLT3-positive acute myeloid leukemia patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gilteritinib
    Italy

  • Study of GBT021601 for Adults and Children with Sickle Cell Disease

    Not yet recruiting

    4 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • (S)-2-Hydroxy-6-((4-(2-(2-Hydroxyethyl)Nicotinoyl)Morpholin-3-Yl)Methoxy)Benzaldehyde
    Belgium France Germany Greece Italy Spain
Previous Page
1 2 3 4 5 6 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!